Literature DB >> 31738882

Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome.

Hui-Mei Wu1, Qiu-Meng Xie2, Cui-Cui Zhao2, Juan Xu2, Xiao-Yun Fan2, Guang-He Fei3.   

Abstract

AIMS: Both CpG oligodeoxynucleotide (CpG-ODN) and melatonin have been reported to induce Th1 response and contribute to allergic asthma resistance. Here, we aimed to reveal how they confer such effect as well as whether they crosstalk with each other. MAIN
METHODS: Six-week-old Female C57BL/6 mice were challenged by OVA to induce allergic airway inflammation, and were treated with CpG-ODN, CpG-ODN plus Luzindole or melatonin respectively. Bronchoalveolar lavage fluid (BALF) cellularity was classified and counted by Wright's-Giemsa staining. HE and PAS staining were used to analyze airway inflammation. The levels of IL-4, IL-5, IL-13,GM-CSF and IFN-γ, as well as IL-1β and IL-18 were analyzed by ELISA. Protein expressions of ASMT, AANAT, NLRP3, IL-1β and caspase-1 in lung tissue were detected by Western blotting, expression of ASMT and AANAT were further observed by immunohistochemistry. KEY
FINDINGS: We found that CpG-ODN considerably suppressed OVA-induced airway leukocytes infiltration, goblet cell hyperplasia and Th2 cytokines production. Furthermore, the resolution effect of CpG-ODN on OVA-induced allergic airway inflammation occurred in parallel with decreased-activation of NLRP3 inflammasome and increased biosynthesis of melatonin. Blocking the effect of endogenous melatonin by Luzindole abolished the suppressive effect of CpG-ODN on OVA-induced airway inflammation and activation of NLRP3 inflammasome, suggesting such effect was mediated by endogenous melatonin. Moreover, exogenous melatonin pronouncedly ameliorated airway inflammation and decreased the activation of NLRP3 inflammasome. SIGNIFICANCE: These results proven that CpG-ODN protects against allergic airway inflammation via suppressing the activation of NLRP3 inflammasome, and such effect may be resulted from the restored-production of melatonin.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic airway inflammation; Biosynthesis; CpG-ODN; Melatonin; NLRP3 inflammasome

Mesh:

Substances:

Year:  2019        PMID: 31738882     DOI: 10.1016/j.lfs.2019.117067

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

Review 1.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

Review 2.  Recent advances in development of nano-carriers for immunogene therapy in various complex disorders.

Authors:  Sanaz Shahgordi; Fatemeh Oroojalian; Ezzat Hashemi; Maryam Hashemi
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

Review 3.  Anti-Inflammatory Activity of Melatonin: a Focus on the Role of NLRP3 Inflammasome.

Authors:  Milad Ashrafizadeh; Masoud Najafi; Nasim Kavyiani; Reza Mohammadinejad; Tahereh Farkhondeh; Saeed Samarghandian
Journal:  Inflammation       Date:  2021-03-02       Impact factor: 4.092

4.  Possible Prophylactic Approach for SARS-CoV-2 Infection by Combination of Melatonin, Vitamin C and Zinc in Animals.

Authors:  Sabiha Fatima; Syed Shams Zaidi; Ashwag Saleh Alsharidah; Feda S Aljaser; Naheed Banu
Journal:  Front Vet Sci       Date:  2020-12-03

5.  CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress.

Authors:  Hai-Yun Zhang; Qiu-Meng Xie; Cui-Cui Zhao; Jia-Feng Sha; Ya Ruan; Hui-Mei Wu
Journal:  J Asthma Allergy       Date:  2021-11-17

Review 6.  Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed.

Authors:  Konrad Kleszczyński; Andrzej T Slominski; Kerstin Steinbrink; Russel J Reiter
Journal:  Nutrients       Date:  2020-08-24       Impact factor: 5.717

Review 7.  The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases.

Authors:  Burak Ibrahim Arioz; Emre Tarakcioglu; Melis Olcum; Sermin Genc
Journal:  Antioxidants (Basel)       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.